FLIR CEO: Many New Fever Entrants "Making Claims That The Science Just Won't Support"

Published Sep 22, 2020 14:40 PM

FLIR's CEO joins a growing number calling out risks with fever / screening systems.

IPVM Image

Last month, IPVM reviewed how Temperature Screening Is Ineffective, Says US, UK, Canada, Israel, And Ireland Health Leaders.

Now, the CEO of FLIR, a company that has been offering such screening for nearly 2 decades is calling out new entrant rivals.

FLIR ********** *** ********

****'* *** ***** ** *** ******** investor ********** ** ********* **, ****. During *** * **** ** *** presentation, ** ***** *** ** *** entrants:

** *** * *** ** *******, becausewe *** * *** ** ***** ***** *** ****** ****** ****** **** *** ******* **** ***'* *******. There are limitations to what thermal can do but if used effectively it can be an incredibly effective tool to screen for folks with elevated skin temperature and that does not mean they are infected there could be a host of reasons. So frankly we have more experience doing this than anyone else in the market. [emphasis added]

** ********** **** ** ****'* **********:

**'** **** ****** ******* ** ******* what ** ******** **** *********** ************ going **** ** *****. ** ** years *** **** *** **** ********, H1N1, *** ** *** ********* **** have *** *** *****. ***** ** years *** ** **** ****** *** only ******* ******* ** ***** ******** technologies ** ** ****. ** ****** a ****** ****** ** **** ** you've ********* **** ******** ** *****, Japan, **** ** ***** **** *** past ****** ******* ******* ** *** have ****** ***** *** ******* *** screening, ** **** **** ***** ***, we've *** * **** ***** ** knowledge ** *** ** ****.

****'* *** *** *** **** *** new ******** ************.

EST ****** ****

****'* *** *** ****** **** **** had ****** ******** ***** ** *** end ** ** **** *** **** it ** **** ***** ****:

*** ******* ****** ** **** ***** a "******-********" $*** ******* ** ******** entering ***** **** **** *****, **** demand *** ******** ******* **** "***-*********** customers" ******* *** *** ******** ** help *** ******.

****** *** ******* **** ** ***** professional **********-***** ********* ****** **** ********* permanent ********* ********** **** ****** *******:

******* *** ****** ******* **** ****** slowed, ***-*********** ********* ****-*** *** ************ enterprise ***** ********* ******* *.*. *********, airports *** ***** **** **** ******** of ****** ** *** *** ** a ******** ** * ****. ****** shifted **** ******** ******* ** **** permanent ******* ********** **** ****** *******.

**** **'** **** ** ** ********* of ******** ******** **** ********* ***** priced ******** ******* ** *** ****** priced **** *************** ********** **** ****** control, *** ******* ** * ******* where ****'** ******** ******, ******** ** workers ******** *** ******** ** * time, **** **** * ******** ********

FLIR's *********** ********* ********

***** ******* ****** ****** **** "******* just ***'* *******" ** * **** issue, **** *** *** ********** ** its ***. **** *******, **'* *** screening ******** *** *** ****** ******** until ****, ***** *** ******* ** **, ** ***** ******** *********:

*** ********'* ***** **** ********* ****** introduced *********** ************ *** ******* **** using *******' ********* ****, **** ***** alerts ********* ** ********' ********* *** cheeks ** *** ********, ** **** as *** ******* ****** *** *******.

************, ******-***'* **** ********* **** *** function **** ***** *** ****, *** provides ********** *** ******** **** ******* are ****, **** ** ********* ** notification **** ********' ******* ** *******.

Science **** ***'* ******* ********

*******, ****** ****, *** ** *** 'fever' / *********** '******' ********* *** now ** **** ******* *********** **** 'tablet' *********** ********* (*******'* ***** ****** ********* *** **+ Relabelers *****).

******* ***** '******* **** ****, *****, Hikvision, ******, ***. *** ******* ** the ***** ** ~$**,***, *** ****** providers *** ******* ** *** ~$*,*** range. *** *********** **** ***** ******* the *** ********** *** ****** ****** who *** ************* **** **** ******** and ********* ***** *** **** **** might ** **** ** *** **** expensive ********.

***** *** ******* *** ********* ***** problems ** **** '******' *** '******' devices, *** ****** ******* ** * category **** **** ******* *****. **** of ***** ******* *** ***** **** low ********** ******* (*.*., ** * 32) *** ********** ************ ********** **** miss ****** **** ******. *** *******, from *** **** ****** ****** ****, the ***** ***** ******* *** ** warmed * ******** ** * **** to ***-***°* (******** ** * *** water *****), *** ****** ******** * "normal" **.*°* ***********.

****** **** *** *** **** ***** which ******** ************, ** ************ ******* ********** ***** ****** *******. Moreover, *** ******* ***** ******* ********.

**** **** ** *********** ** *** is ****, ** ********, *** *** or ***** ******* ****** ** ***** such *******.

Comments (6)
Avatar
Brian Karas
Sep 22, 2020
Pelican Zero

* **** ** *****, * ** kind ** ********* *** "***** ******" hype ***** ** ***** *****.

** ***** ******* **** ***** ********* I ***** **** ******** * ******* of ***** **** ***** ******** *** claims ** "****" ** *** ** terms ** ******** ******** ******. ***** are **** ************* *** *********** ***** promoting *** ***** ****** *******, *** I ** *** ******* **** ** terms ** ********** ***********.

***** **** ** *** ******* ****-**-**** initiatives **** **** ***** *** ***** figuring *** *** ************** *** ************* factors.

(4)
UM
Undisclosed Manufacturer #2
Sep 22, 2020

** ***** *** **** * **** to **** ** **** ** ****, this ** **! ** *** ******* you ** **** **** *** **** of ********, ** ****** ** *** to "*****"

UM
Undisclosed Manufacturer #1
Sep 22, 2020

"*** ** **** *********** ** *** be ** ********** ********* **** ** screen *** ***** **** ******** **** temperature..."

** ******* "******" **** **** ******* cameras *** ** **** *** ******** temperature ************?

** ****** ***** ** ** **** confusion ** *** *********** **** ** many *********** ***** ***** *********.

(1)
(1)
(1)
(1)
Avatar
Alexander Ignatenko
Sep 22, 2020
Luxriot

*****'* * ***** ** *** ******* but **** ** ** * ********/********* person ******. ***** * *** ** a ******* ******* ******* *****'* **** one ** ****** ** ******* *******. Neither **** * ****** ** ******** Administration/Marketing. **** *** ****** ** *** an ******. ******.

(5)
jl
johnny lindstrom
Sep 24, 2020

*****'* ******** *** **** ****. **** "new" ******** **** **** ********** **** the ********** ***** **** **** **, Alabama ****** ******** ** *** ** many ********. ***** **** ****** **** were *** **** ******* ***** *********** back ** *** **** ** **** there ** ******* ******* ********* ******* that *** **** ** *********** ** that **** ** ****. ***** ********* Systems ** * ***** ******* ** comparison ** **** * ******* **** are *** ** *** **** ********* that *** **** ********** *** ************* Mass ***** ********* ******* ************ *** along. **** **** *** ******** ***** some ** ***** ***** ******** *** operational ******, *** ** ****** *** since ******** *** *** ****** * fine *******. ********* ******* ** *** of *** **** **** **** ***** Screening ******* ** *** ****** ** the ***** ***** **** **** ********. The ****** *** *** **** ****** effective, **** ******** ******** ****** ****** many ******** ** *********** ***** ** a ********* ** ****** ****** ***** continents *** *** **** ******** ** deployments **** ** *** ****** ***** April.

RH
Rik Heller
Oct 14, 2020

*** **** ****** ***** ********* ** not *******, ****** **** ** *** implementations ** **** ******* ***. ** is *** ******* ** ********** ******** and *********** ** ********* *** ********* and **** *** ******** ** *** measurement **** ***** ***** ** *** feel **** ** ********* ******* **** 50% ** *** ********** ** ** undetected, ** ***** *********. *** **** associated **** *** **** ** "********-*********" in ********** ***** *** ********** ***** and *** ***** ** ******** **** greatly ***** ***** ********* ** ******** for * **** ** **** ********* must ***** - ***** *********.

***** **** *** ******** ** *********** and ***** ***** ******** ** *** the ****** ****** ******** ******* ***.** as * **** ****** *** *********. 100.4F ** * ****** **** *** scientific ******* ******** **** **** **. It ** *********** ***** *** ********* of **************. ** ****, ** ***** in *** ****** *** **** ***** an **** *********** ** **.**, * human *******. **** *********** ** **** what ***-******* *********** ** ********** **, clinically.

******* **** *** **** ** ***** with ******* **** **,*** *** *,***,*** well ******, *********** ******* **** ******* human *********** ** **.*-**.** *** ***** therefore *** ** ** *** ** 98.6 ****** ***, ******, *** ****-**-*** dependent - *** ****** **** ** be ********* ********* ******* *********** **** the *******.

******* ** *** ******* ******** ********* of ******* ***-******* ************, **** ******* accuracy ** *********** *** ****** ******* of ***** ***** ** *******, ***** negatives (********** **************) *** ******* ** even ******* *******.